Bobde, Shravani
Sohn, Woo-Yun
Bekkat-Berkani, Rafik
Banzhoff, Angelika
Cavounidis, Athena
Dinleyici, Ener Cagri
Rodriguez, Wilfrido Coronell
Ninis, Nelly
Funding for this research was provided by:
GSK
Article History
Received: 10 October 2023
Accepted: 14 December 2023
First Online: 29 January 2024
Declarations
:
: Shravani Bobde, Woo-Yun Sohn, Rafik Bekkat-Berkani, and Athena Cavounidis are employees of GSK and may hold stock or stock options. Shravani Bobde holds patents on antimicrobial peptides and related methods issued prior to employment at GSK and before this work began. Angelika Banzhoff was an employee of GSK, holding stock or stock options when this study was undertaken. Ener Cagri Dinleyici performs contract work for the Eskisehir Osmangazi University funded by GSK, Pfizer, and Sanofi Pasteur. Wilfrido Coronell Rodriguez has received honoraria from Merck Sharp & Dohme and Sanofi Pasteur, and has participated on advisory boards at GSK, Pfizer, and Sanofi Pasteur. Nelly Ninis has received payment and/or honoraria from GSK.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.